Cargando…
A preliminary study of micro-RNAs as minimally invasive biomarkers for the diagnosis of prostate cancer patients
BACKGROUND: A prostate cancer diagnosis is based on biopsy sampling that is an invasive, expensive procedure, and doesn’t accurately represent multifocal disease. METHODS: To establish a model using plasma miRs to distinguish Prostate cancer patients from non-cancer controls, we enrolled 600 patient...
Autores principales: | Giglio, Simona, De Nunzio, Cosimo, Cirombella, Roberto, Stoppacciaro, Antonella, Faruq, Omar, Volinia, Stefano, Baldassarre, Gustavo, Tubaro, Andrea, Ishii, Hideshi, Croce, Carlo M., Vecchione, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903618/ https://www.ncbi.nlm.nih.gov/pubmed/33622375 http://dx.doi.org/10.1186/s13046-021-01875-0 |
Ejemplares similares
-
Autophagy deactivation is associated with severe prostatic inflammation in patients with lower urinary tract symptoms and benign prostatic hyperplasia
por: De Nunzio, Cosimo, et al.
Publicado: (2017) -
miRNAs as Candidate Biomarker for the Accurate Detection of Atypical Endometrial Hyperplasia/Endometrial Intraepithelial Neoplasia
por: Giglio, Simona, et al.
Publicado: (2019) -
Fez1/Lzts1 a new mitotic regulator implicated in cancer development
por: Vecchione, Andrea, et al.
Publicado: (2007) -
LZTS1 downregulation confers paclitaxel resistance and is associated with worse prognosis in breast cancer
por: Lovat, Francesca, et al.
Publicado: (2013) -
microRNA: Diagnostic Perspective
por: Faruq, Omar, et al.
Publicado: (2015)